.webp?width=217&height=60&name=Screenpoint-Med%20(1).webp "Screen Point Medical")
.png?width=500&height=500&name=ARR_SPM_1%20(1).png)
Alejandro Rodríguez-Ruiz, PhD
Vice President of Clinical Strategy and Innovation at ScreenPoint Medical
As VP of Innovation & Clinical Strategy at ScreenPoint Medical, Alejandro leads the innovation and clinical strategy department, driving the development of advanced AI solutions in breast imaging to improve cancer prevention, detection, treatment and patient outcomes. He oversees product innovation, clinical validation, and strategic initiatives that bridge cutting-edge research with real-world clinical needs, ensuring our technologies deliver measurable impact for radiologists, oncologists, healthcare providers, and patients worldwide.
He served as a Clinical Research Scientist at ScreenPoint Medical from 2018 to 2021 before serving as a Validation Lead at Philips and a Product Manager at Nicolab before returning to ScreenPoint Medical in 2023.
He received his PhD in Medical Sciences from Radboud University in the Netherlands with a successful defense on the topic of assessment and optimization of the clinical use of tomosynthesis and artificial intelligence for early breast cancer detection.
He has also received Bachelor's Degrees in Physics from the University of Valencia, KTH Royal Institute of Technology, and Universitat de Barcelona as well as a Master's Degree in Medical Physics from Universidad Complutense de Madrid. He resides in the Netherlands.